#CannesLions2022: Diversity, equity and inclusion takes center stage as pharma industry is called to action

Nicole DeFeudis

Editor

CANNES — Diversity, equity and inclusion are not about ticking a box or wearing a badge, health marketing group Omnicom Health stressed in a recent report …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

#CannesLions2022: Diversity, equity and inclusion takes center stage as pharma industry is called to action

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

BioMarin turns to ex-Roche dealmaker James Sabry to build ‘next version’ of 27-year-old company

Purdue, Sacklers reach new $7.4B opioid settlement after SCOTUS rejection

As another Trump term gets underway, pharma advisors get comfortable with uncertainty

AbbVie partners with Neomorph in latest molecular glue deal

China's biotech boom is threatening US drugmakers' dominance

Fueling More Breakthroughs: Manufacturing Innovation to Expand Gene Therapy’s Reach

#Can­nes­Lions2022: Di­ver­si­ty, eq­ui­ty and in­clu­sion takes cen­ter stage as phar­ma in­dus­try is called to ac­tion

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

#CannesLions2022: Diversity, equity and inclusion takes center stage as pharma industry is called to action